Free Newsletter
Genetic mutations slow aging process in centenarians
Forget those studies of long-lived Italian shepherds and Greek fishermen. It's not fresh air or exercise or a simple whole-foods diet that causes certain people to live past 100, a new study shows. Instead, it's a set of genetic mutations thought to interfere with normal cell growth and thus slow aging.
Dr. Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine in New York, found the mutations exclusively among centenarians. They affect sensitivity to insulin growth factor 1, which is crucial to children's growth and contributes to regeneration throughout adulthood.
Earlier studies had shown that mice lacking one copy of the IGF-1 gene live 26 percent longer than normal, on average, and damping down that metabolic pathway extended the lifespan of yeasts, worms, and flies.
- read the report from The Guardian
- check out the article in The Telegraph
Related Articles:
Anti-aging study finds enzymes protect cells. Report
Biotechs pursue anti-aging treatments. Report
Ingredient in wine may boost longevity, health. Report
Longevity gene may be key to living past 100. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: